Medical Research
(H30)
INTERNATIONAL MYELOMA SOCIETY
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2023
$11.4M
Total Revenue
$9.4M
Total Expenses
N/A
Net Assets
1
Employees
Expense Breakdown
Program Expense Ratio
N/A
Fundraising Efficiency
N/A
Operating Reserve
N/A
Liability-to-Asset
N/A
Revenue Diversification
N/A
Executive Compensation
$0
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2023 | $11.4M | $9.4M | N/A | — | 1 |
| 2022 | $3.6M | $2.6M | N/A | — | 1 |
| 2021 | $4.5M | $1.8M | N/A | — | 1 |
Donor Reviews
No reviews yet
Be the first to share your experience with this organization.